SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042912
Filing Date
2019-11-12
Accepted
2019-11-12 16:11:25
Documents
63
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q logc-10q_20190930.htm 10-Q 1862769
2 EX-10.2 logc-ex102_166.htm EX-10.2 74659
3 EX-31.1 logc-ex311_8.htm EX-31.1 13881
4 EX-31.2 logc-ex312_9.htm EX-31.2 13743
5 EX-32.1 logc-ex321_7.htm EX-32.1 7626
  Complete submission text file 0001564590-19-042912.txt   5399445

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT logc-20190930.xml EX-101.INS 929170
7 XBRL TAXONOMY EXTENSION SCHEMA logc-20190930.xsd EX-101.SCH 42315
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE logc-20190930_cal.xml EX-101.CAL 47146
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE logc-20190930_def.xml EX-101.DEF 114409
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20190930_lab.xml EX-101.LAB 337529
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20190930_pre.xml EX-101.PRE 241488
Mailing Address 99 ERIE STREET CAMBRIDGE MA 02139
Business Address 99 ERIE STREET CAMBRIDGE MA 02139 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38707 | Film No.: 191209478
SIC: 2836 Biological Products, (No Diagnostic Substances)